These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 2117640

  • 41. Characterization of immunosuppressive functions of murine peritoneal macrophages induced with various agents.
    Tomioka H, Saito H.
    J Leukoc Biol; 1992 Jan; 51(1):24-31. PubMed ID: 1740643
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Immunomodulatory effects of cold stress on mice infected intraperitoneally with a 50% lethal dose of Toxoplasma gondii.
    Aviles H, Monroy FP.
    Neuroimmunomodulation; 2001 Jan; 9(1):6-12. PubMed ID: 11435747
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Modulation of Mycobacterium avium growth in murine macrophages: reversal of unresponsiveness to interferon-gamma by indomethacin or interleukin-4.
    Denis M, Gregg EO.
    J Leukoc Biol; 1991 Jan; 49(1):65-72. PubMed ID: 1898613
    [Abstract] [Full Text] [Related]

  • 47. Defects in cell-mediated immunity affect chronic, but not innate, resistance of mice to Mycobacterium avium infection.
    Doherty TM, Sher A.
    J Immunol; 1997 May 15; 158(10):4822-31. PubMed ID: 9144497
    [Abstract] [Full Text] [Related]

  • 48. Effects of the Chinese traditional medicine mao-bushi-saishin-to on therapeutic efficacy of a new benzoxazinorifamycin, KRM-1648, against Mycobacterium avium infection in mice.
    Shimizu T, Tomioka H, Sato K, Sano C, Akaki T, Dekio S, Yamada Y, Kamei T, Shibata H, Higashi N.
    Antimicrob Agents Chemother; 1999 Mar 15; 43(3):514-9. PubMed ID: 10049260
    [Abstract] [Full Text] [Related]

  • 49. Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation.
    Oswald IP, Wynn TA, Sher A, James SL.
    Proc Natl Acad Sci U S A; 1992 Sep 15; 89(18):8676-80. PubMed ID: 1528880
    [Abstract] [Full Text] [Related]

  • 50. Evaluation of the inflammatory response in macrophages stimulated with exosomes secreted by Mycobacterium avium-infected macrophages.
    Wang J, Yao Y, Xiong J, Wu J, Tang X, Li G.
    Biomed Res Int; 2015 Sep 15; 2015():658421. PubMed ID: 25861639
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Natural killer cell-dependent mycobacteriostatic and mycobactericidal activity in human macrophages.
    Bermudez LE, Young LS.
    J Immunol; 1991 Jan 01; 146(1):265-70. PubMed ID: 1898601
    [Abstract] [Full Text] [Related]

  • 53. Ethanol affects release of TNF and GM-CSF and membrane expression of TNF receptors by human macrophages.
    Bermudez LE, Wu M, Martinelli J, Young LS.
    Lymphokine Cytokine Res; 1991 Oct 01; 10(5):413-9. PubMed ID: 1662988
    [Abstract] [Full Text] [Related]

  • 54. Tumor necrosis factor-alpha in combination with interferon-gamma, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes.
    Bogdan C, Moll H, Solbach W, Röllinghoff M.
    Eur J Immunol; 1990 May 01; 20(5):1131-5. PubMed ID: 2113475
    [Abstract] [Full Text] [Related]

  • 55. HIV-1 infection of human macrophages impairs phagocytosis and killing of Toxoplasma gondii.
    Biggs BA, Hewish M, Kent S, Hayes K, Crowe SM.
    J Immunol; 1995 Jun 01; 154(11):6132-9. PubMed ID: 7751654
    [Abstract] [Full Text] [Related]

  • 56. Induction of macrophage nitric oxide production by interferon-gamma and tumor necrosis factor-alpha is enhanced by interleukin-10.
    Corradin SB, Fasel N, Buchmüller-Rouiller Y, Ransijn A, Smith J, Mauël J.
    Eur J Immunol; 1993 Aug 01; 23(8):2045-8. PubMed ID: 7688311
    [Abstract] [Full Text] [Related]

  • 57. Mycobacterial growth inhibition by interferon-gamma-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis.
    Flesch I, Kaufmann SH.
    J Immunol; 1987 Jun 15; 138(12):4408-13. PubMed ID: 3108389
    [Abstract] [Full Text] [Related]

  • 58. Cytokine priming reduces dependence on TNF-R2 for TNF-alpha-mediated induction of macrophage nitric oxide generation.
    Miller AR, Suttles J, Stout RD.
    J Interferon Cytokine Res; 1996 Dec 15; 16(12):1055-63. PubMed ID: 8974009
    [Abstract] [Full Text] [Related]

  • 59. Cellular defenses against Toxoplasma gondii in newborns.
    Wilson CB, Haas JE.
    J Clin Invest; 1984 Jun 15; 73(6):1606-16. PubMed ID: 6327765
    [Abstract] [Full Text] [Related]

  • 60. In vivo-activated mononuclear phagocytes and protective immunity to chlamydiae in mice.
    Huebner RE, Byrne GI.
    Infect Immun; 1988 Jun 15; 56(6):1492-9. PubMed ID: 3131246
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.